Striatal histone modifications in models of levodopa-induced dyskinesia.
AuthorsNicholas, Anthony P.
Lubin, Farah D.
Hallett, Penelope J.
Fox, Susan H.
Brotchie, Jonathan M.
Sweatt, J. David
Standaert, David G.
AffiliationUniversity of Alabama at Birmingham
MetadataShow full item record
AbstractDespite recent advances in the treatment of Parkinson disease (PD), levodopa remains the most effective and widely used therapy. A major limitation to the use of levodopa is the development of abnormal involuntary movements, termed levodopa-induced dyskinesia (LDID), following chronic levodopa treatment. Since recent studies have suggested that modifications of chromatin structure may be responsible for many long-lasting changes in brain function, we have examined post-translational modifications of striatal histones in two models of LDID: an acute murine model and a chronic macaque monkey model, both exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the primate model, which closely resembles human LDID, we observed that chronic levodopa and the appearance of LDID was associated with marked deacetylation of histone H4, hyperacetylation and dephosphorylation of histone H3, and enhancement of the phosphorylation of extracellular signal-regulated kinase (ERK). In the murine model of acutely rather than chronically induced LDID, dopamine depletion and levodopa treatment also induced deacetylation of histone H4 and phosphorylation of ERK, but histone H3 exhibited decreased trimethylation and reduced rather than enhanced acetylation. These data demonstrate striking changes in striatal histones associated with the induction of LDID in both animal models. The pattern of changes observed, as well as the behavioral features, differed in the two models. However, both models exhibit marked deacetylation of histone H4, suggesting that inhibitors of H4 deacetylation may be useful in preventing or reversing LDID.
CitationStriatal histone modifications in models of levodopa-induced dyskinesia. 2008, 106 (1):486-494 J. Neurochem.
JournalJournal of neurochemistry
- Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
- Authors: Darmopil S, Martín AB, De Diego IR, Ares S, Moratalla R
- Issue date: 2009 Sep 15
- ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
- Authors: Pavón N, Martín AB, Mendialdua A, Moratalla R
- Issue date: 2006 Jan 1
- Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
- Authors: Lebel M, Chagniel L, Bureau G, Cyr M
- Issue date: 2010 Apr
- Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
- Authors: Errico F, Bonito-Oliva A, Bagetta V, Vitucci D, Romano R, Zianni E, Napolitano F, Marinucci S, Di Luca M, Calabresi P, Fisone G, Carta M, Picconi B, Gardoni F, Usiello A
- Issue date: 2011 Dec
- Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
- Authors: Fox SH, Henry B, Hill M, Crossman A, Brotchie J
- Issue date: 2002 Nov